Inventor

SOUZA FABIO E S

CA30 patents

⚠️ This page may combine multiple inventors who share the name “SOUZA FABIO E S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SOUZA FABIO E S

APOTEX INC

Crystalline form of Remdesivir

Crystalline forms of ibrutinib

Processes for the preparation of apalutamide and intermediates thereof

Crystalline form of Eluxadoline

Salt of cabozantinib

Crystalline forms of niraparib tosylate

Crystalline forms of Tenofovir alafenamide

Crystalline forms of Ponatinib hydrochloride

Processes for the preparation of zuclomiphene and intermediates thereof

Crystalline forms of zuclomiphene citrate

Processes for the preparation of zuclomiphene intermediates

Crystalline forms of Acalabrutinib

Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2

Crystalline form of Olaparib

Crystalline form of Ribociclib succinate

Crystalline form of Eluxadoline

Crystalline form of lumacaftor

Crystalline form of selexipag

Processes for the preparation of multicomponent crystalline forms of active pharmaceutical ingredients using solvent vapour

Zuclomiphene salts and crystalline forms thereof

ALPHORA RES INC

Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein

Synthetic route to dronabinol

2-((2S,3S,4R,5R)-5-((S)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl)tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation

3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof

Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof

Process for preparation of (3R)-2,4-di-leaving group-3-methylbut-1-ene

Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives and intermediates useful thereof

Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein

Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing-SO2-(p-tolyl) groups

SANDOZ AG

Crystalline derivatives of (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-YL)-3-aminopropan-2-ol